hydroxyurea has been researched along with AIDS Seroconversion in 5 studies
Excerpt | Relevance | Reference |
---|---|---|
"Hydroxyurea mainly acts as a ribonucleotide reductase inhibitor and can positively modulate the activity of several pyrimidine and purine analogues." | 2.69 | Hydroxyurea toxicity combined with didanosine (ddl) in HIV-1-seropositive asymptomatic individuals. ( Foli, A; Lisziewicz, J; Lori, F; Maserati, R; Seminari, E; Tinelli, C, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boelaert, JR | 1 |
Dom, GM | 1 |
Huitema, AD | 1 |
Beijnen, JH | 1 |
Lange, JM | 1 |
Biron, F | 1 |
Lucht, F | 1 |
Peyramond, D | 1 |
Fresard, A | 1 |
Vallet, T | 1 |
Nugier, F | 1 |
Grange, J | 1 |
Malley, S | 1 |
Hamedi-Sangsari, F | 1 |
Vila, J | 1 |
Simonelli, C | 1 |
Nasti, G | 1 |
Vaccher, E | 1 |
Tirelli, U | 1 |
Zanussi, S | 1 |
De Paoli, P | 1 |
Comar, M | 1 |
Giacca, M | 1 |
Weissman, SB | 1 |
Sinclair, GI | 1 |
Green, CL | 1 |
Fissell, WH | 1 |
Seminari, E | 1 |
Lisziewicz, J | 1 |
Tinelli, C | 1 |
Foli, A | 1 |
Lori, F | 1 |
Maserati, R | 1 |
2 trials available for hydroxyurea and AIDS Seroconversion
Article | Year |
---|---|
Anti-HIV activity of the combination of didanosine and hydroxyurea in HIV-1-infected individuals.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Drug Tolerance | 1995 |
Hydroxyurea toxicity combined with didanosine (ddl) in HIV-1-seropositive asymptomatic individuals.
Topics: Adult; Anti-HIV Agents; Bone Marrow; Didanosine; Drug Synergism; Drug Therapy, Combination; Female; | 1999 |
3 other studies available for hydroxyurea and AIDS Seroconversion
Article | Year |
---|---|
The boosting of didanosine by allopurinol permits a halving of the didanosine dosage.
Topics: Adult; Allopurinol; Anti-HIV Agents; Didanosine; Drug Interactions; Drug Therapy, Combination; Enzym | 2002 |
Hydroxyurea treatment in HIV-infected patients.
Topics: Adult; Aged; Antiviral Agents; Female; HIV Seropositivity; Humans; Hydroxyurea; Male; Middle Aged | 1996 |
Hydroxyurea-induced hepatitis in human immunodeficiency virus-positive patients.
Topics: Adult; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Female; HIV Seropositivity; Humans; | 1999 |